SCHEMBL6788083

SCHEMBL6788083

Cc1ccc(S(=O)(=O)Oc2ccc(-c3ccccc3C(=O)O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.51
MEN1 O00255 3/20 0.51
ALDH1A1 P00352 4/20 0.48
LMNA P02545 1/20 0.48
PPARG P37231 1/20 0.48
PTPN1 P18031 2/20 0.47
ENPP2 Q13822 3/20 0.47
ADAMTS4 O75173 1/20 0.46
VDR P11473 1/20 0.46
CA12 O43570 2/20 0.45
CA2 P00918 2/20 0.45
NPC1 O15118 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
ENPP3 O14638 3/20 0.44
ENPP1 P22413 3/20 0.44
CYP2C9 P11712 2/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6937794 0.81 CA2 (0.62) KMT2AMEN1ALDH1A1LMNAPPARG
SCHEMBL24604538 0.81 CA2 (0.62) KMT2AMEN1ALDH1A1LMNAPPARG
SCHEMBL372 0.81 KMT2A (0.60) KMT2AMEN1ALDH1A1NPC1GAA
SCHEMBL31402608 0.81 KMT2A (0.60) KMT2AMEN1ALDH1A1NPC1GAA
Hydrochloric Acid SCHEMBL7610390 0.80 KMT2A (0.59) KMT2AMEN1ALDH1A1NPC1GAA
SCHEMBL6795409 0.78 POLB (0.45) KMT2AMEN1GAA
SCHEMBL346667 0.78 HTT (0.59) KMT2AMEN1ALDH1A1LMNAPPARG
SCHEMBL6937173 0.78 CA2 (0.64) KMT2AMEN1ALDH1A1LMNAPPARG
SCHEMBL2237142 0.78 TDP1 (0.67) KMT2AMEN1ALDH1A1LMNAPPARG
SCHEMBL3976179 0.77 MAPT (0.56) KMT2AMEN1ALDH1A1LMNAVDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 KMT2A 2457/4885MEN1 2426/4885ALDH1A1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.